PREPAREDNESS FOR AND RESPONSE TO MENINGOCOCCAL OUTBREAKS: A PILOT STUDY OF THE IMMUNOGENICITY, REACTOGENICITY AND TOLERABILITY OF TWO SCHEDULES OF A 4CMENB VACCINE IN ADOLESCENTS AND YOUNG ADULTS
- Registry ID
- CT11
- Source registry
- HEALTH_CANADA
- Status
- Pending
- Study type
- INTERVENTIONAL
- Sponsor
- DALHOUSIE UNIVERSITY
- Last update
- 2015-09-16
Conditions
Related clinical trials
- A PHASE IIIB, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO EVALUATE SAFETY AND IMMUNOGENICITY OF GSK¿S MENINGOCOCCAL ABCWY VACCINE WHEN ADMINISTERED IN HEALTHY ADOLESCENTS AND ADULTS, PREVIOUSLY PRIMED WITH MENINGOCOCCAL ACWY VACCINE
- A PHASE 2B, RANDOMIZED, CONTROLLED, OBSERVER-BLIND, MULTI-CENTER, NON-INFERIORITY IMMUNOGENICITY AND SAFETY STUDY OF TWO FORMULATIONS OF GSK BIOLOGICALS¿ MENINGOCOCCAL ACWY CONJUGATE VACCINE
- A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL TO ASSESS THE LOT-TO-LOT CONSISTENCY OF SCI-B-VAC IN ADULTS
- A PHASE 3 DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL TO COMPARE THE IMMUNOGENICITY AND SAFETY OF A THREE-DOSE REGIMEN OF SCI-B-VAC TO A THREE-DOSE REGIMEN OF ENGERIX-B IN ADULTS
- A PHASE 3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER
- VACCINATING CHILDREN AFTER CHEMOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA
View on source registry